Previous Article | Next Article ![]()
Infection and Immunity, January 2003, p. 95-100, Vol. 71, No. 1
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.1.95-100.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Britta Schulte Holthausen,1,
Werner Goebel,1 Kwang Sik Kim,2 and Michael Kuhn1*
Lehrstuhl für Mikrobiologie, Theodor-Boveri-Institut für Biowissenschaften der Universität Würzburg, Würzburg, Germany,1 Pediatric Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland2
Received 8 July 2002/ Returned for modification 6 September 2002/ Accepted 30 September 2002
|
|
|---|
|
|
|---|
In the present study we analyzed the roles of normal human serum (HS) and fetal calf serum (FCS) in adhesion to and invasion of HBMEC by L. monocytogenes. We show that antibodies present in HS result in a dramatic decrease in HBMEC invasion. This finding may not only help to explain some of the discrepancies among recent publications on InlB-dependent invasion of endothelial cells by L. monocytogenes but also question the in vivo role of InlB-dependent invasion of endothelial cells in the course of human infections.
|
|
|---|
HBMEC were isolated from a brain biopsy specimen of an adult female with epilepsy and were cultured by methods described previously (19). HBMEC were subsequently immortalized by transfection with simian virus 40 large T antigen and maintained their morphological and functional characteristics for at least 30 passages (20). HBMEC were cultured in gelatin-coated flasks without the addition of antibiotics in complete HBMEC medium (RPMI 1640 medium [Gibco] supplemented with FCS [10%] [Gibco or Sigma], NuSerum IV [10%] [Becton Dickinson, Bedford, Mass.], nonessential amino acids [1%] and vitamins [1%], heparin [5 U/ml], sodium pyruvate [1 mM], L-glutamine [2 mM], and endothelial cell growth supplement [30 µg/ml] [all from Sigma]) and were incubated at 37°C under a humid atmosphere of 5% CO2. Caco-2 epithelial cells and J774 macrophages were cultured in RPMI 1640 medium supplemented with FCS (10%) according to standard procedures (2).
Forty-eight hours prior to infection, cells were split and seeded into normal (Caco-2 cells and J774 macrophages) or gelatin-treated 24-well tissue culture plates at a density of 105 cells per well. Immediately prior to the assay, each well was found to contain approximately 2 x 105 cells. Bacteria were diluted in RPMI 1640 medium, with or without serum, and 1 ml of the suspension was added to each monolayer in order to obtain the desired multiplicity of infection of 20 bacteria per cell.
To measure initial association, cultures were incubated at 37°C for 1 h in order to allow the bacteria to associate with the cells, which were then washed five times and lysed, and appropriate dilutions were plated on BHI agar. To measure invasion, cultures were incubated at 37°C for 1 h in order to allow the bacteria to invade the cells. One milliliter of RPMI medium containing 100 µg of gentamicin (Sigma)/ml was then added to the washed monolayers to kill extracellular bacteria, and the plates were further incubated for 1 h at 37°C. After the cells were washed twice with PBS, they were lysed and plated on BHI agar. All cellular association and invasion assays were performed in triplicate and repeated at least three times. The absolute numbers of intracellular bacteria were always around 105 bacteria per well, which means that about 5% of the bacteria added to the cells were taken up by the HBMEC.
For statistical analysis, the two-tailed, unpaired Student t test was applied, and P values of
0.01 were considered statistically significant. Invasion and early association efficiencies were always compared to those for the untreated control, which was set to 100% invasion or association. Values for invasion upon addition of serum or immunoglobulins are presented relative to the control.
Preparation of bacterial proteins and Western blot analysis. One milliliter of L. monocytogenes grown overnight in BHI broth (Difco) was centrifuged, and the pellet was resuspended in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) buffer and heated to 100°C for 10 min in order to prepare a lysate of total listerial proteins. The proteins present in the culture supernatant were precipitated by addition of 10% (vol/vol) trichloroacetic acid, harvested by centrifugation, and also resuspended in SDS-PAGE buffer and heated as described above. SDS-PAGE, transfer of the proteins onto nitrocellulose membranes, and detection with horseradish peroxidase-conjugated secondary antibodies were carried out by standard procedures (18).
HS and human immunoglobulins. Commercially available pooled HS preparations (Sigma Chemicals, St. Louis, Mo.), heat inactivated for 30 min at 56°C, were used in all experiments. HS was fractionated by centrifugation for 30 min through Centricon filters which retain proteins larger than 100 kDa. Both fractions were then used either as supplements in cellular infection assays or as primary antisera in Western blots with the separated listerial proteins as targets. Human immunoglobulins (5 mg/ml) were either from Sandoz (Basel, Switzerland) (Sandoglobin; complement free) or from Sigma Chemicals. Human newborn serum (cord serum) was obtained as described previously (14).
Preadsorption of immunoglobulins.
Immunoglobulins (Sigma Chemicals) were incubated overnight with either L. monocytogenes EGD, L. monocytogenes
inlAB (12), Bacillus subtilis 168, or Escherichia coli K-12 in order to remove strain- or species-specific antibodies from the immunoglobulin preparation. Bacteria were grown to mid-log phase as described above and washed twice with PBS, and 1010 bacteria were incubated with 0.5 ml of the immunoglobulins (5 mg/ml) overnight at 4°C with shaking. The bacteria were then removed by two rounds of centrifugation, and the supernatant (preadsorbed immunoglobulins) was tested for inhibitory activity in the invasion assay.
|
|
|---|
![]() View larger version (16K): [in a new window] |
FIG. 1. Early association of L. monocytogenes EGD with HBMEC in the presence of HS and FCS. Cells were infected with L. monocytogenes, and associated bacteria were counted at 60 min postinfection. Association after infection in RPMI medium was compared with association after infection in the presence of 10% HS or 10% FCS. Associated bacteria were enumerated, and the numbers of bacteria recovered (expressed as percentages of the number recovered for the untreated control, taken as 100%) are shown. Values are means and standard deviations (error bars) of the results of a representative experiment. In all figures, open bars indicate that differences from the control are statistically significant; shaded bars represent experimental results that are not statistically significantly different from those for the control.
|
![]() View larger version (41K): [in a new window] |
FIG. 2. Invasion of HBMEC by L. monocytogenes EGD in the presence of different concentrations of HS (top; logarithmic scale) or FCS (bottom; linear scale). Cells were infected with L. monocytogenes EGD for 60 min. The infected cells were then washed and treated further with gentamicin for 60 min, and intracellular bacteria were enumerated. The numbers of bacteria recovered (expressed as percentages of the number recovered for the untreated control, taken as 100%) are shown. Values are means and standard deviations (error bars) of the results of one representative experiment. FCS treatment was performed with FCS from two sources: Sigma (left bars) and Gibco (right bars). Open versus shaded bars are explained in the legend to Fig. 1.
|
![]() View larger version (49K): [in a new window] |
FIG. 3. L. monocytogenes uptake by J774 macrophages (top) and Caco-2 epithelial cells (bottom) in the presence of 10% HS or 10% FCS. Cells were infected with L. monocytogenes EGD for 60 min. The infected cells were then washed and treated further with gentamicin for 60 min, and intracellular bacteria were enumerated. The numbers of bacteria recovered (expressed as percentages of the number recovered for the untreated control, taken as 100%) are shown. Values are means and standard deviations (error bars) of the results of representative experiments. Open versus shaded bars are explained in the legend to Fig. 1.
|
![]() View larger version (34K): [in a new window] |
FIG. 4. Invasion of HBMEC by L. monocytogenes EGD after preincubation of either the bacteria or the HBMEC with HS. Prior to infection, either the bacteria (left) or the HBMEC (right) were incubated in RPMI medium containing 10% HS for 1 h at 37°C. Preincubated HBMEC were washed once and infected with untreated L. monocytogenes for 60 min as described in Materials and Methods. Preincubated listeriae were collected by centrifugation, resuspended in RPMI medium, and used for infection of untreated HBMEC for 60 min as described in Materials and Methods. Intracellular bacteria were enumerated after an additional 60 min of incubation in the presence of gentamicin. The numbers of bacteria recovered (expressed as percentages of the number recovered for the untreated control, taken as 100%) are shown. Values are means and standard deviations (error bars) of the results of a representative experiment. Open versus shaded bars are explained in the legend to Fig. 1.
|
![]() View larger version (33K): [in a new window] |
FIG. 5. Fractionation of HS and testing for the presence of antibodies and for inhibitory activity. HS was fractionated as described in Materials and Methods. (Top) Both fractions were tested for the presence of anti-Listeria antibodies by Western-blotting. Listerial proteins (whole-cell lysates in lanes 1 and 3; supernatant proteins in lanes 2 and 4) prepared as described in Materials and Methods were separated on an SDS-10% PAGE gel, transferred to a nitrocellulose membrane, and probed with both fractions of the HS to detect the presence of anti-Listeria antibodies (the high-molecular-weight fraction was used to develop the left two lanes; the low-molecular-weight fraction was used for the right two lanes). Several proteins found both in the whole-cell preparation and in the supernatant were recognized only by the high-molecular-weight fraction of HS, clearly demonstrating the presence of anti-Listeria antibodies. (Bottom) Both fractions were also tested for inhibition of HBMEC invasion as described in the legend to Fig. 2. Values are means and standard deviations (error bars) of the results of representative experiments. As expected, only the high-molecular-weight fraction containing the antibodies inhibited the invasion of HBMEC by L. monocytogenes. Open versus shaded bars are explained in the legend to Fig. 1.
|
inlAB. As expected, preincubation with L. monocytogenes EGD or L. monocytogenes
inlAB resulted in a significant reduction in the inhibitory activity of the immunoglobulins (Fig. 7) in the invasion assay. Preincubation of the immunoglobulins with either E. coli or B. subtilis resulted in no reduction in the inhibitory activity (Fig. 7). These results clearly show that the removal of the Listeria-specific antibodies alone leads to a loss of inhibitory activity.
![]() View larger version (45K): [in a new window] |
FIG. 6. Invasion of HBMEC by L. monocytogenes EGD in the presence of different concentrations of the immunglobulin fraction of HS. Cells were infected with L. monocytogenes EGD for 60 min. The infected cells were then washed and treated further with gentamicin for 60 min, and intracellular bacteria were enumerated. The numbers of bacteria recovered (expressed as percentages of the number recovered for the untreated control, taken as 100%) are shown. Values are means and standard deviations (error bars) of the results of representative experiments. Open versus shaded bars are explained in the legend to Fig. 1. (Top) IgG from Sandoz; (bottom) IgG from Sigma.
|
![]() View larger version (21K): [in a new window] |
FIG. 7. Invasion of HBMEC by L. monocytogenes EGD in the presence of preadsorbed immunglobulins. Cells were infected with L. monocytogenes EGD for 60 min either without (control) or with immunoglobulins (IgG) as controls. In parallel, the cells were also infected with L. monocytogenes in the presence of immunoglobulins (5%) preadsorbed with either L. monocytogenes (IgG + L. mono.), E. coli (IgG + E. coli), B. subtilis (IgG + B. subtilis), or L. monocytogenes inlAB (IgG + inlAB). The infected cells were then washed and treated further with gentamicin for 60 min, and intracellular bacteria were enumerated. The numbers of bacteria recovered (expressed as percentages of the number recovered for the untreated control, taken as 100%) are shown. Values are means and standard deviations (error bars) of the results of one representative experiment. Open bars indicate that differences from the control are statistically significant.
|
![]() View larger version (29K): [in a new window] |
FIG. 8. Invasion of HBMEC by L. monocytogenes EGD in the presence of different concentrations of newborn human serum (cord serum). Cells were infected with L. monocytogenes EGD for 60 min. The infected cells were then washed and treated further with gentamicin for 60 min, and intracellular bacteria were enumerated. The numbers of bacteria recovered (expressed as percentages of the number recovered for the untreated control, taken as 100%) are shown. Values are means and standard deviations (error bars) of the results of one representative experiment. Open versus shaded bars are explained in the legend to Fig. 1.
|
|
|
|---|
The role of InlB in the invasion of microvascular endothelial cells in vivo is not known. However, the ability to invade and grow in endothelial cells is believed to be an important feature that is necessary for crossing the blood-brain barrier or the placental barrier (21). Knowledge about factors modulating this InlB-dependent endothelial cell invasion in vitro and in vivo would therefore be of great importance for understanding of the mechanisms used by L. monocytogenes to interact with endothelial cells in order to cross the blood-brain barrier.
The data presented here clearly demonstrate that HS significantly impairs L. monocytogenes invasion of HBMEC. The finding that the presence of 1% HS reduces the invasive capacity of L. monocytogenes for HBMEC more than 200-fold now challenges the in vivo relevance of the in vitro finding on endothelial cell invasion by L. monocytogenes. As it is known from animal studies that septicemia and hence the presence of bacteria in the bloodstream is required for CNS invasion (1, 21), the data presented here question whether free L. monocytogenes in the bloodstream might be able to directly infect microvascular endothelial cells in vivo in the presence of serum. Possibly, other mechanisms such as cell-to-cell spread from infected monocytes or leukocytes into endothelial cells, as already described in reports of in vitro (5, 11) and in vivo (4) studies, might be more important for the crossing of the blood-brain barrier by L. monocytogenes than direct infection of microvascular endothelial cells by bacteria that are free in the bloodstream.
In contrast to HS, FCS, which is regularly used as an additive in cell culture media, inhibited L. monocytogenes uptake by HBMEC only slightly and at much higher concentrations, demonstrating the specificity of the inhibitory activity of HS. This activity of HS on invasion was found not to be restricted to HBMEC: invasion of Caco-2 epithelial cells was also inhibited by HS and not by FCS. However, epithelial cells are normally not in contact with serum compounds as are endothelial cells, and hence it is not clear whether serum-dependent inhibition of epithelial cell invasion could play any role during L. monocytogenes infection in vivo. In contrast to uptake by epithelial cells, uptake of L. monocytogenes by macrophages, which is independent of the internalins, is not reduced the presence of HS.
In the search for the inhibitory component of HS, we first tested human albumin fractions, which were, however, inactive. Secondly, we fractionated HS by centrifugation and found that only the high-molecular-weight fraction inhibited L. monocytogenes invasion of HBMEC. This high-molecular-weight fraction also contains high concentrations of anti-Listeria antibodies. To confirm that the antibodies are responsible for the inhibition, we tested two commercial preparations of human immunoglobulins. Both inhibited L. monocytogenes invasion of HBMEC in a dose-dependent manor. In immunoprecipitation experiments with either L. monocytogenes, B. subtilis, or E. coli, we could significantly deplete the inhibitory antibodies in the immunoglobulin fraction only by pretreatment with L. monocytogenes, confirming our assumption that inhibition of L. monocytogenes invasion is not a general effect of any type of antibodies present but that specifically the anti-Listeria antibodies are inhibitory in the HBMEC invasion assay. Preincubation of the immunoglobulins with the L. monocytogenes
inlAB mutant also led to a reduction in the inhibitory activity of the immunoglobulins. Initially we expected that preincubation with an L. monocytogenes strain lacking the InlA and InlB proteins would result in an immunoglobulin fraction still harboring the potentially inhibitory anti-InlB antibodies. However, one must keep in mind that L. monocytogenes harbors 20 genes coding for internalin-like molecules, some of which are highly homologous to the inlB gene (3, 9). Preincubation of the immunoglobulins with a strain expressing these closely related internalins and internalin-like proteins might hence result in the removal of InlB-specific antibodies even in the absence of InlB, due to a cross-reactivity of the respective antibodies.
Anti-Listeria antibodies are regularly found in HS from healthy donors (8, 15). The finding that these antibodies drastically inhibit the invasion of HBMEC by L. monocytogenes is very interesting for several reasons. On the one hand, it has previously been shown that anti-Listeria antibodies in HS act as opsonins in the uptake of L. monocytogenes by dendritic cells, thereby increasing invasion of these antigen-presenting cells significantly (15). On the other hand, the humoral immune response to infection with L. monocytogenes was for a long time regarded as not being involved in the clearance of an infection (13). However, it was recently demonstrated that monoclonal anti-listeriolysin antibodies can provide resistance in mice to L. monocytogenes infection when administered prior to challenge with virulent listeriae (6). Our data on the inhibitory effect of anti-Listeria antibodies present in HS on the direct infection of HBMEC by L. monocytogenes in vitro suggest that the progression of an infection from septicemia to meningitis and encephalitis could be strongly impaired by anti-Listeria antibodies present in the blood of most adult humans.
Human newborns or fetuses lack a fully functional immune system. Human newborn serum derived from umbilical cords (cord serum) was hence tested for inhibition of L. monocytogenes invasion of HBMEC and found to be much less active (only 45% inhibition at a concentration of 1% in contrast to more than 99% inhibition with adult serum at the same concentration). This result might help to explain the high susceptibility of newborns to L. monocytogenes infections, since their endothelial cells are obviously much less protected against invasion by L. monocytogenes free in the bloodstream than are the endothelial cells of adults (at least if our in vitro data also hold true for the in vivo situation). This putative increased ability of L. monocytogenes to invade endothelial cells in newborns may contribute directly to the higher susceptibility of newborns, compared to adults, to severe, life-threatening L. monocytogenes infections.
The data presented here could also help to clarify some recent conflicts in determining the role of the internalins InlA and InlB in endothelial cell invasion (5, 11, 12, 17, 22). Some of the conflicting results can probably be explained by the use of different infection media containing either FCS or HS at different concentrations, variables which, as we now know, significantly influence the outcome of standard gentamicin-based infection assays with endothelial cells as targets.
We thank J. Kreft and T. Williams for critical reading of the manuscript.
Present address: Drug Innovation and Approval, Aventis Pharma Deutschland GmbH, 65926 Frankfurt am Main, Germany. ![]()
Present address: Max-Planck-Institut für Vaskuläre Biologie, 48149 Münster, Germany. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»